Elisabeth Carilla-Durand

Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia

Françis C. Colpaert, J.P. Tarayre, Wouter Koek et al. · Neuropharmacology · 2002 · 136 citations

Molecular Pharmacology, Pain Syndrome, Health Sciences +14

F15599, a highly selective post-synaptic 5-HT1A receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity

Marie‐Bernadette Assié, Laurent Bardin, Agnès L. Auclair et al. · The International Journal of Neuropsychopharmacology · 2010 · 106 citations · Full text

In-vivo Profile, Neurotransmitter, Psychopharmacology +21

Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release

Cristina Cosi, Elisabeth Carilla-Durand, M.B. Assié et al. · European Journal of Pharmacology · 2006 · 88 citations

Psychiatry, Functional Selectivity, Medicine +9

F 11440, a Potent, Selective, High Efficacy 5-HT1AReceptor Agonist with Marked Anxiolytic and Antidepressant Potential

Wouter Koek, Jean‐François Patoiseau, M.B. Assié et al. · Journal of Pharmacology and Experimental Therapeutics · 1998 · 63 citations

The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: Comparison with aripiprazole, ziprasidone, bifeprunox and F15063

Marie‐Bernadette Assié, Elisabeth Carilla-Durand, Laurent Bardin et al. · European Journal of Pharmacology · 2008 · 54 citations

Psychoactive Drug, Psychiatry, Medicine +9